Between 2022 and 2024, the Medical Research Future Fund (MRFF) invested $1.38 billion in new health and medical research projects across Australia. This investment was distributed through 578 competitive grants focused on a variety of priority areas such as First Nations health, clinical trials, regional, rural and remote health, public health, health services, and consumer-led research. The MRFF supports research that addresses real-world health challenges, aiming to improve outcomes for diverse communities.
The MRFF report highlights the fund’s strong emphasis on commercializing medical research, especially supporting small and medium enterprises. Several programs assist research discoveries to move from early ideas through to clinical implementation, helping to translate innovation into practical healthcare solutions. Funding reached all Australian states and territories, with Victoria receiving the largest share at 42.2%, while most other regions received funding near the national average of 21.5%.
Universities lead the majority of MRFF-funded projects, managing 519 out of the 578 grants. However, these grants often involve collaborative efforts that span multiple institutions and locations across Australia, reflecting a nationwide commitment to advancing medical research.
The MRFF report provides detailed insights into how funding aligns with priorities set by the Australian Medical Research Advisory Board from 2022 to 2024, including information on grant selection processes, policy and performance activities, and other government support for medical research. The fund continues to be a critical driver of innovation aimed at tackling Australia’s most pressing health priorities.
